Get the Stockscreener App
2.46
1.99%
-0.05
After Hours:
2.46
Cerus Corp stock is traded at $2.46, with a volume of 750.80K.
It is down -1.99% in the last 24 hours and down -2.38% over the past month.
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.
See More
Previous Close:
$2.51
Open:
$2.49
24h Volume:
750.80K
Relative Volume:
0.30
Market Cap:
$495.75M
Revenue:
$216.56M
Net Income/Loss:
$-9.57M
P/E Ratio:
-49.50
EPS:
-0.0497
Net Cash Flow:
$-1.22M
1W Performance:
-4.28%
1M Performance:
-2.38%
6M Performance:
+38.98%
1Y Performance:
+108.47%
1-Day Range:
$2.46
$2.515
1-Week Range:
$2.46
$2.60
52-Week Range:
$1.19
$3.4698
Cerus Corp Stock (CERS) Company Profile
Name
Cerus Corp
Sector
Industry
Phone
(925) 288-6000
Address
1220 CONCORD AVENUE, CONCORD, CA
Compare CERS vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
2.46 | 505.83M | 216.56M | -9.57M | -1.22M | -0.0497 |
ABT
Abbott Laboratories
|
103.36 | 182.09B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
91.62 | 117.54B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
270.01 | 105.63B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.10 | 65.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.77 | 49.67B | 6.30B | 1.07B | 1.09B | 1.8406 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-12-24 | Initiated | Craig Hallum | Buy |
| Jan-20-23 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-17-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-08-20 | Resumed | BTIG Research | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| Feb-26-20 | Initiated | BTIG Research | Buy |
| Nov-13-19 | Upgrade | BTIG Research | Neutral → Buy |
| Aug-28-19 | Initiated | Stifel | Buy |
| Aug-23-19 | Resumed | Stephens | Overweight |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Dec-08-17 | Resumed | BTIG Research | Neutral |
| Jul-07-16 | Resumed | Cantor Fitzgerald | Buy |
| Dec-17-15 | Downgrade | Wedbush | Outperform → Neutral |
| May-02-14 | Reiterated | MLV & Co | Buy |
| Apr-24-13 | Reiterated | Cantor Fitzgerald | Buy |
| Mar-15-13 | Reiterated | MLV & Co | Buy |
| Apr-17-12 | Initiated | Cantor Fitzgerald | Buy |
| Feb-29-12 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-10-11 | Reiterated | MLV & Co | Buy |
| Jun-03-11 | Initiated | Wedbush | Outperform |
| Mar-04-11 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-09-10 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-26-09 | Upgrade | Avondale | Mkt Perform → Mkt Outperform |
View All
Cerus Corp Stock (CERS) Latest News
Bank of New York Mellon Corp Invests $1.64 Million in Cerus Corporation $CERS - MarketBeat
Cerus Stock Price Forecast. Should You Buy CERS? - StockInvest.us
Cerus (NASDAQ:CERS) Upgraded at Wall Street Zen - MarketBeat
BlackRock Inc. Invests $64.87 Million in Cerus Corporation $CERS - marketbeat.com
Connor Clark & Lunn Investment Management Ltd. Invests $1.37 Million in Cerus Corporation $CERS - MarketBeat
Cerus Corporation (CERS) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Algert Global LLC Has $4.35 Million Stock Position in Cerus Corporation $CERS - marketbeat.com
781,800 Shares in Cerus Corporation $CERS Bought by Primecap Management Co. CA - MarketBeat
Cerus Corporation (NASDAQ:CERS): When Will It Breakeven? - Moomoo
Globeflex Capital L P Makes New Investment in Cerus Corporation $CERS - marketbeat.com
Ieq Capital LLC Buys Shares of 2,406,330 Cerus Corporation $CERS - marketbeat.com
CERS Initiates Coverage On Freedom Broker -- Price Target Announ - GuruFocus
Cerus (CERS) Quarter in Focus: The Available Earnings Metric Delivers a Beat in Latest Trading; Price Reaction: The Stock Gains 3.26% in the Current UpdateGAAP Earnings Report - dars.gov.et
Cerus: This Blood-Safety Underdog Should Be Earning More Respect (NASDAQ:CERS) - Seeking Alpha
Cerus Corp chief legal officer sells $89,529 in company stock. By Investing.com - Investing.com Canada
Cerus Corp (CERS) Chief Legal Officer Chrystal Jensen Sells 30,0 - GuruFocus
Cerus Corp chief legal officer sells $89,529 in company stock. - Investing.com
Cerus (CERS) legal chief sells 30,000 shares in preset plan - Stock Titan
CERS Q2 2026 Earnings: Narrower-Than-Expected Loss Meets Muted Market ResponseRevenue Report - vinanet.vn
Cerus (NASDAQ: CERS) insider moves to sell more stock after July sale - Stock Titan
CERS Q2 2026 Earnings: Narrower-than-Expected Loss Delivers Positive SurpriseNet Profit Margin - vinanet.vn
Assenagon Asset Management S.A. Has $920,000 Stock Holdings in Cerus Corporation $CERS - MarketBeat
Cerus (NASDAQ:CERS) Downgraded by Wall Street Zen to Hold - MarketBeat
Cerus Corporation (CERS) Climbs 4.93% to $2.98, Extending Recovery Toward Key ResistancePCR Spike - vinanet.vn
Baker Bros. cuts Cerus Corporation (CERS) position to 3.2% ownership stake - Stock Titan
Cerus Corp (CERS): ARK Investment, Catherine Wood report 8.95% ownership stake - Stock Titan
Cerus Corp (CERS) sees Soleus Capital group report 1.2% beneficial stake - Stock Titan
Wasatch Advisors LP Sells 1,897,237 Shares of Cerus Corporation $CERS - MarketBeat
Cerus Corporation 2026 Q2ResultsEarnings Call Presentation (NASDAQ:CERS) 2026-08-08 - Seeking Alpha
Cerus Corp (CERS) Stock News Today - tradingkey.com
Cerus Corp (CERS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cerus (CERS) Institutional Ownership 2026 $CERS - MarketBeat
Cerus Corporation Q2 2026 10-Q Report: Financial Statements, Risk Factors, and SEC Filings Overview - Minichart
CERS Looks 26.3% Overvalued on GF Value™ - GuruFocus
Cerus Corp (NASDAQ:CERS) Drops 10% After Q2 Revenue Beat Overshadowed by Lowered Full-Year Guidance - ChartMill
Cerus Q2 revenue rises to $63.3 million - Quiver Quantitative
Cerus reports Q2 2026 revenue $63.3M; product revenue $57.4M, raises 2026 product guidance - TradingView
Cerus: Q2 Earnings Snapshot - KING5.com
CERS Q1 2026 Earnings: EPS Surprises to the Upside, Stock SlipsEPS Miss Report - vinanet.vn
Cerus Corp expected to post a loss of 1 cent a shareEarnings Preview - TradingView
CERS|Cerus Corp|Price:3.065|Chg%:+0.135 - TradingKey
Cerus Corp (CERS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cerus Corp (CERS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cerus Corp (CERS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cerus Corp (CERS) Cash Flow - TradingKey
Cerus Corp (CERS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cerus Corp (CERS) Income Statement - TradingKey
Cerus Corp (CERS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CERS|Cerus Corp|Price:2.845|Chg%:+0.135 - TradingKey
Cerus (CERS) to Announce Quarterly Earnings on Thursday - MarketBeat
CERS Q1 2026 Earnings: EPS Surpasses Estimates by 75% as Narrower Loss ReportedPost-Announcement Reaction - vinanet.vn
Cerus Corp Stock (CERS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.29%
0.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):